516 related articles for article (PubMed ID: 18842733)
21. Mechanism of translation initiation on hepatitis C virus RNA.
Nomoto A; Tsukiyama-Kohara K; Kohara M
Princess Takamatsu Symp; 1995; 25():111-9. PubMed ID: 8875615
[TBL] [Abstract][Full Text] [Related]
22. Complete 5' noncoding region is necessary for the efficient internal initiation of hepatitis C virus RNA.
Fukushi S; Katayama K; Kurihara C; Ishiyama N; Hoshino FB; Ando T; Oya A
Biochem Biophys Res Commun; 1994 Mar; 199(2):425-32. PubMed ID: 8135783
[TBL] [Abstract][Full Text] [Related]
23. The pathway of HCV IRES-mediated translation initiation.
Otto GA; Puglisi JD
Cell; 2004 Oct; 119(3):369-80. PubMed ID: 15507208
[TBL] [Abstract][Full Text] [Related]
24. Coordinated assembly of human translation initiation complexes by the hepatitis C virus internal ribosome entry site RNA.
Ji H; Fraser CS; Yu Y; Leary J; Doudna JA
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):16990-5. PubMed ID: 15563596
[TBL] [Abstract][Full Text] [Related]
25. Structural and mechanistic insights into hepatitis C viral translation initiation.
Fraser CS; Doudna JA
Nat Rev Microbiol; 2007 Jan; 5(1):29-38. PubMed ID: 17128284
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus (HCV) NS2 protein up-regulates HCV IRES-dependent translation and down-regulates NS5B RdRp activity.
She Y; Liao Q; Chen X; Ye L; Wu Z
Arch Virol; 2008; 153(11):1991-7. PubMed ID: 18853100
[TBL] [Abstract][Full Text] [Related]
27. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
[TBL] [Abstract][Full Text] [Related]
28. Translational insensitivity to potent activation of PKR by HCV IRES RNA.
Shimoike T; McKenna SA; Lindhout DA; Puglisi JD
Antiviral Res; 2009 Sep; 83(3):228-37. PubMed ID: 19467267
[TBL] [Abstract][Full Text] [Related]
29. Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES.
Kikuchi K; Umehara T; Nishikawa F; Fukuda K; Hasegawa T; Nishikawa S
Biochem Biophys Res Commun; 2009 Aug; 386(1):118-23. PubMed ID: 19501043
[TBL] [Abstract][Full Text] [Related]
30. Interfering with hepatitis C virus IRES activity using RNA molecules identified by a novel in vitro selection method.
Romero-López C; Barroso-delJesus A; Puerta-Fernández E; Berzal-Herranz A
Biol Chem; 2005 Feb; 386(2):183-90. PubMed ID: 15843163
[TBL] [Abstract][Full Text] [Related]
31. HuR, a protein implicated in oncogene and growth factor mRNA decay, binds to the 3' ends of hepatitis C virus RNA of both polarities.
Spångberg K; Wiklund L; Schwartz S
Virology; 2000 Sep; 274(2):378-90. PubMed ID: 10964780
[TBL] [Abstract][Full Text] [Related]
32. A conserved RNA structure within the HCV IRES eIF3-binding site.
Collier AJ; Gallego J; Klinck R; Cole PT; Harris SJ; Harrison GP; Aboul-Ela F; Varani G; Walker S
Nat Struct Biol; 2002 May; 9(5):375-80. PubMed ID: 11927954
[TBL] [Abstract][Full Text] [Related]
33. Differential effects on the hepatitis C virus (HCV) internal ribosome entry site by vitamin B12 and the HCV core protein.
Li D; Lott WB; Martyn J; Haqshenas G; Gowans EJ
J Virol; 2004 Nov; 78(21):12075-81. PubMed ID: 15479850
[TBL] [Abstract][Full Text] [Related]
34. Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells.
Kanda T; Yokosuka O; Imazeki F; Fujiwara K; Nagao K; Saisho H
Biochem Biophys Res Commun; 2005 Jun; 331(2):621-9. PubMed ID: 15850805
[TBL] [Abstract][Full Text] [Related]
35. The interaction between human initiation factor eIF3 subunit c and heat-shock protein 90: a necessary factor for translation mediated by the hepatitis C virus internal ribosome entry site.
Ujino S; Nishitsuji H; Sugiyama R; Suzuki H; Hishiki T; Sugiyama K; Shimotohno K; Takaku H
Virus Res; 2012 Jan; 163(1):390-5. PubMed ID: 22016036
[TBL] [Abstract][Full Text] [Related]
36. The hepatitis C virus internal ribosome-entry site: a new target for antiviral research.
Gallego J; Varani G
Biochem Soc Trans; 2002 Apr; 30(2):140-5. PubMed ID: 12023841
[TBL] [Abstract][Full Text] [Related]
37. Autogenous translational inhibition of core protein: implication for switch from translation to RNA replication in hepatitis C virus.
Zhang J; Yamada O; Yoshida H; Iwai T; Araki H
Virology; 2002 Feb; 293(1):141-50. PubMed ID: 11853407
[TBL] [Abstract][Full Text] [Related]
38. Cellular proteins specifically bind to the 5'-noncoding region of hepatitis C virus RNA.
Yen JH; Chang SC; Hu CR; Chu SC; Lin SS; Hsieh YS; Chang MF
Virology; 1995 Apr; 208(2):723-32. PubMed ID: 7747444
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C IRES: translating translation into a therapeutic target.
Jubin R
Curr Opin Mol Ther; 2001 Jun; 3(3):278-87. PubMed ID: 11497352
[TBL] [Abstract][Full Text] [Related]
40. A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice.
McCaffrey AP; Meuse L; Karimi M; Contag CH; Kay MA
Hepatology; 2003 Aug; 38(2):503-8. PubMed ID: 12883495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
